Datavault AI Inc. has completed the second phase of its equity financing arrangement with Scilex Holding Company, solidifying a major cryptocurrency-backed investment that underscores the growing intersection of digital assets and corporate financing. The transaction involved Datavault issuing a Scilex pre-funded warrant for 263,914,094 shares of its common stock in exchange for approximately 1,237.6 Bitcoin, following stockholder approval of both the warrant share issuance and an increase in authorized shares during the company's November 24, 2025 annual meeting.
This financing tranche builds upon Scilex's initial investment made on September 26, 2025, creating a substantial financial foundation for Datavault's strategic initiatives. The capital infusion is specifically designated to strengthen Datavault's digital asset reserves, expand its supercomputing infrastructure, and support overall platform growth. These developments occur as both companies advance their artificial intelligence collaboration, which includes a worldwide exclusive biotech-sector license agreement featuring up to $2.55 billion in potential milestones and scheduled upfront payments continuing through September 2026.
The transaction represents one of the most significant Bitcoin-based corporate financing deals in recent memory, highlighting the evolving role of cryptocurrency in traditional business operations. For investors and industry observers, the deal demonstrates how established companies are increasingly incorporating digital assets into their financial strategies. The scale of the Bitcoin transaction—valued at millions of dollars based on current market rates—signals confidence in both cryptocurrency as a store of value and Datavault's strategic direction.
Datavault's technology platform focuses on AI experience, valuation, and monetization of assets within the Web 3.0 environment. The company operates through two primary divisions: Acoustic Science and Data Science. The Acoustic Science Division features patented technologies including WiSA, ADIO, and Sumerian, which represent industry-first foundational spatial and multichannel wireless HD sound transmission technologies with intellectual property covering audio timing, synchronization, and multi-channel interference cancellation.
The Data Science Division leverages Web 3.0 capabilities and high-performance computing to provide solutions for experiential data perception, valuation, and secure monetization. The company's Information Data Exchange enables Digital Twins and licensing of name, image, and likeness by securely attaching physical real-world objects to immutable metadata objects, fostering responsible AI with integrity. Additional information about the company is available at https://ibn.fm/DVLT.
This financing arrangement has broader implications for the technology and financial sectors, particularly regarding how companies manage digital asset reserves and incorporate cryptocurrency into corporate treasury strategies. The deal also highlights the growing importance of AI infrastructure investment as companies position themselves for the next phase of technological advancement. The collaboration between Datavault and Scilex represents a significant commitment to biotech sector innovation through their exclusive licensing agreement, potentially driving advancements in healthcare and life sciences.
For the investment community, this transaction demonstrates the evolving nature of corporate financing, where traditional equity arrangements now incorporate digital assets as legitimate consideration. The stockholder approval process required for both the warrant issuance and share authorization increase indicates proper corporate governance procedures were followed, providing transparency and accountability to shareholders. As companies continue to navigate the intersection of traditional finance and emerging digital assets, transactions like this may establish precedents for future corporate financing structures.
